摘要
目的评价肾康注射液治疗老年糖尿病肾病综合征的效果及对Scr、BUN指标的影响。方法样本选取时间:2018年4月~2020年4月,研究主体:临清市人民医院收治的70例老年糖尿病肾病综合征病例样本,以随机双盲法将样本分为两组,35例入对比组给予常规治疗,35例入研究组加用肾康注射液,对比分析治疗效果。结果研究组临床综合有效率高于对比组,差异显著(P<0.05)。治疗前,两组Scr、BUN、24h尿蛋白总量等指标差异较小(P>0.05);治疗后,研究组Scr、BUN、24h尿蛋白总量等指标明显优于对比组,差异显著(P<0.05)。研究组并发症发生率低于对比组,差异显著(P<0.05)。结论在老年糖尿病肾病综合征治疗中应用肾康注射液,有助进一步提高治疗效果,改善肾功能指标,且能够降低并发症发生率,临床应用价值可观,具有采纳价值。
Objective To evaluate the effect of Shenkang injection on senile diabetic nephrotic syndrome and its effect on Scr、BUN indexes.Methods Sample interval:from April 2018 to April 2020,study subjects:A sample of 70 elderly diabetic nephrotic syndrome cases admitted to Linqing People's Hospital,35 cases were given routine treatment in contrast group,35 cases were added to study group with Shenkang injection,and the treatment effect was compared and analyzed.Results The clinical effective rate of study group was higher than that of contrast group(P<0.05).The difference between the two groups was small before treatment(P>0.05);After treatment,the total amount of Scr、BUN、24 hour urine protein in the study group was significantly better than that in the contrast group(P<0.05).The incidence of complications in the study group was lower than that in the contrast group,and the difference was significant(P<0.05).Conclusion The application of Shenkang injection in the treatment of senile diabetic nephrotic syndrome can help to further improve the therapeutic effect,improve the renal function index,and can reduce the incidence of complications.The clinical application value is considerable and has the adoption value.
作者
姜海生
JIANG Hai-sheng(Department of Geriatrics and Nephrology,Linqing People's Hospital,Shandong Linqing,252600,China)
出处
《中华养生保健》
2021年第3期1-3,共3页
CHINESE HEALTH CARE
关键词
老年
糖尿病肾病综合征
肾康注射液
肾功能
old age
diabetic nephrotic syndrome
Shenkang injection
effect
renal function